Wordt geladen...
Secukinumab for ankylosing spondylitis and psoriatic arthritis
The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively changed since the introduction of anti-TNFα drugs. These treatments were shown to reduce the symptoms and signs of the diseases and improve the quality of life. However, a variable percentage of patients do not res...
Bewaard in:
| Gepubliceerd in: | Ther Clin Risk Manag |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5085310/ https://ncbi.nlm.nih.gov/pubmed/27799780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S100091 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|